Fairmount Funds Management LLC 13D and 13G filings for Jade Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-08 4:15 pm Purchase | 2025-10-06 | 13D | Jade Biosciences, Inc. JBIO | Fairmount Funds Management LLC | 10,353,875 19.990% | 3,104,519 (+42.82%) | Filing |
| 2025-05-01 6:31 pm Purchase | 2025-04-28 | 13D | Jade Biosciences, Inc. JBIO | Fairmount Funds Management LLC | 7,249,356 19.990% | 7,249,356 (New Position) | Filing |